Keywords: geneva, appoints, david, hurley, president, ceo, novartis

Geneva Appoints David Hurley as President and CEO

Article | 07 January 1999

Print This

- Novartis AG subsidiary Geneva Pharmaceuticals, a genericsmanufacturer, has appointed David Hurley to the post of president and chief executive.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in